Lateralization After IntraMedullary Nailing of InterTrochanteric Hip Fractures, Clinical and Radiographic Outcomes
LIMIT
1 other identifier
observational
60
1 country
1
Brief Summary
Intertrochanteric fractures are commonly stabilized using an intramedullary nail with a lag screw that enters the lateral cortex of the femur. This lag screw commonly protrudes during the healing process and may cause implant related pain. This study will help determine if implant related pain is different depending to the lag screw design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2021
CompletedStudy Start
First participant enrolled
October 4, 2021
CompletedFirst Posted
Study publicly available on registry
October 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 23, 2024
CompletedJuly 30, 2024
July 1, 2024
2.4 years
October 4, 2021
July 26, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Pain at lag screw
Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)
6 weeks
Pain at lag screw
Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)
12 weeks
Pain at lag screw
Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)
21 weeks
Pain at lag screw
Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)
52 weeks
Secondary Outcomes (3)
Radiographic lateralization of lag screw
52 weeks
Incidence of lag screw injections
52 weeks
Reoperation rate
52 weeks
Study Arms (3)
Telescoping Lag Screw
Intertrochanteric fractures treated with Arthrex Hip Nail with Telescoping Screw
Standard lag Screw
Intertrochanteric fractures treated with Zimmer Natural Nail Cephalomedullary Nail
Standard lag screw with addition of worm screw
Intertrochanteric fractures treated with Smith and Nephew TRIGEN INTERTAN
Interventions
Intertrochanteric fracture fixation using Arthrex Hip Nail with Telescoping Lag Screw
Intertrochanteric fracture fixation using Zimmer Natural Nail Cephalomedullary Nail using standard lag screw
Intertrochanteric fracture fixation using Smith and Nephew TRIGEN INTERTAN with addition of worm screw
Eligibility Criteria
Patients sustaining an intertrochantic hip fracture
You may qualify if:
- Patients greater than or equal to 22 years of age who undergo treatment of an intertrochanteric hip fracture with an intramedullary nail.
- Fluoroscopic views of the final fixation construct or a post-operative radiograph taken within 24 hours must be available.
You may not qualify if:
- Non-ambulatory prior to injury (patient must do more than only transfers)
- Cognitive deficiencies that prevent the patient from providing their own informed consent
- Inability to follow-up at the discretion of the investigator (incarceration, moving out of area, no permanent housing)
- Prior fracture to injured hip
- Prior surgery to injured hip
- Basi-cervical fracture pattern (fracture that begins above the lesser trochanter and exits medial to the greater trochanter)
- Patients not treated within 48 hours of admission
- Chronic or acute infection at site of surgery
- Language barrier preventing completion of study forms in English
- Open fracture
- Fracture related to neoplasm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prisma Health-Upstatelead
- Arthrex, Inc.collaborator
Study Sites (1)
Greenville Memorial Hosptial
Greenville, South Carolina, 29605, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John D Adams, MD
Prisma Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2021
First Posted
October 26, 2021
Study Start
October 4, 2021
Primary Completion
February 23, 2024
Study Completion
February 23, 2024
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share